Vemurafenib (VEM) in relapsed refractory multiple myeloma harboring BRAF(V600) mutations (V600m): A cohort of the histology-independent VE-basket study Meeting Abstract
| Authors: | Raje, N.; Chau, I.; Hyman, D. M.; Ribrag, V.; Blay, J. Y.; Tabernero, J.; Elez-Fernandez, M. E.; Wolf, J. S.; Sirzen, F.; Yee, A.; Faris, J.; Kaiser, M.; Landau, H.; Michot, J. M.; Veronese, L.; Makrutzki, M.; Lasserre, S. F.; Puzanov, I.; Baselga, J. |
| Abstract Title: | Vemurafenib (VEM) in relapsed refractory multiple myeloma harboring BRAF(V600) mutations (V600m): A cohort of the histology-independent VE-basket study |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368021801205 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.4263.4263 |
| Notes: | Meeting Abstract: 4263 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work